Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Pharmacol Ther. 2008 Oct 29;121(1):100–114. doi: 10.1016/j.pharmthera.2008.10.003

Table 2.

Drug discrimination studies in which the putative antagonism of GHB by another drug was studied.

Training drug (dose, route) Drug(s) studied with GHB Species % Decrease of GHB-appropriate responding

GHB (56 mg/kg, im) CGP35348 Pigeon (Carneau)a 67%
Ketamine 8%
GHB (100 mg/kg, im) CGP35348 68%
DTT 0%
Ketamine 17%
GHB (178 mg/kg, im) CGP35348 90%
DTT 6%
Flumazenil 17%
Haloperidol 9%
Ketamine 0%
NCS-382 0%

GHB (100 mg/kg, im) CGP35348 Pigeon (Carneau)b 76%
Flumazenil 17%
Haloperidol 17%
Naltrexone 11%
NCS-382 9%

GHB (100 mg/kg, im) GHV Pigeon (Carneau)c 13%

GHB (100 mg/kg, im) 3-HPA Pigeon (Carneau)d 9%
UMB 72 25%
UMB 86 27%

GHB (200 mg/kg, ip) CGP35348 Rat (Sprague-Dawley)e 64%

GHB (200 mg/kg, ip) CGP35348 Rat (Sprague-Dawley)f 81%
Flumazenil 16%
NCS-382 54%

GHB (200 mg/kg GHB, ip) vs. CGP35348 Rat (Sprague-Dawley)g 73%
saline or baclofen CGP52432 82%
DTT 33%
NCS-382 44%
UMB 86 18%
GHB (200 mg/kg GHB, ip) vs. CGP35348 87%
saline, baclofen, or diazepam CGP52432 93%
DTT 62%
NCS-382 37%
UMB 86 50%

GHB (200 mg/kg, ip) 3-HPA Rat (Sprague-Dawley)d 39%
UMB 72 31%
UMB 86 16%

GHB (200 mg/kg, ip) GHV Rat (Sprague-Dawley)c 39%
Baclofen (3.2 mg/kg, ip) GHV 37%h

GHB (300 mg/kg GHB, ig) vs. CGP35348 Rat (Sprague-Dawley)i 94%j
1 g/kg ethanol NCS-382 79%

GHB (300 mg/kg, ig) CGP35348 Rat (Sprague-Dawley)k 80%j
NCS-382 45%

GHB (300 mg/kg, ig) CGP35348 Rat (Long Evans)l 65%j
GHB (700 mg/kg, ig) CGP35348 85%j

GHB (300 mg/kg, ig) NCS-382 Rat (Long Evans)m 92%j
GHB (700 mg/kg, ig) NCS-382 88%j

GHB (600 mg/kg, ig) DTT Rats (Long Evans)n 80%j

Baclofen (3.2 mg/kg, ip) CGP35348 Rat (Sprague-Dawley)o 78%